Get the Stockscreener App
5.28
5.39%
0.27
Sight Sciences Inc stock is traded at $5.28, with a volume of 281.61K.
It is up +5.39% in the last 24 hours and up +8.64% over the past month.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
See More
Previous Close:
$5.01
Open:
$5.12
24h Volume:
281.61K
Relative Volume:
1.11
Market Cap:
$287.28M
Revenue:
$79.55M
Net Income/Loss:
$-37.25M
P/E Ratio:
-7.4851
EPS:
-0.7054
Net Cash Flow:
$-25.40M
1W Performance:
+10.23%
1M Performance:
+8.64%
6M Performance:
-36.08%
1Y Performance:
+23.65%
1-Day Range:
$5.07
$5.33
1-Week Range:
$4.87
$5.33
52-Week Range:
$3.11
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences Inc
Sector
Industry
Phone
(415) 889-0550
Address
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
5.28 | 287.28M | 79.55M | -37.25M | -25.40M | -0.7054 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-08-25 | Upgrade | Lake Street | Hold → Buy |
| Dec-06-24 | Initiated | UBS | Buy |
| Nov-04-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-21-24 | Initiated | Lake Street | Buy |
| Sep-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-23 | Upgrade | Stifel | Hold → Buy |
| Oct-04-22 | Initiated | Needham | Hold |
| Jul-26-22 | Initiated | Stifel | Hold |
| Feb-03-22 | Initiated | William Blair | Outperform |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Sight Sciences Inc Stock (SGHT) Latest News
Sight Sciences Inc (SGHT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sight Sciences Inc (SGHT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sight Sciences Inc (SGHT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sight Sciences Inc (SGHT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sight Sciences Inc (SGHT) Institutional Confidence - TradingKey
Sight Sciences Inc (SGHT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sight Sciences Inc (SGHT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sight Sciences Inc (SGHT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sight Sciences Inc (SGHT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sight Sciences director Encrantz buys $68,793 in company stock By Investing.com - Investing.com Nigeria
Sight Sciences director Encrantz buys $68,793 in company stock - Investing.com
Sight Sciences (SGHT) director boosts direct stake with 14,100-share buy - Stock Titan
Sight Sciences | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Discover 3 Promising Penny Stocks With Market Caps Over $20M - Sahm
Number of shareholders of Sight Sciences, Inc. – NASDAQ:SGHT - TradingView
Sight Sciences Shareholders Reelect Directors, Ratify Auditor - The Globe and Mail
Sight Sciences (SGHT) Dips 3.26% as Medical Device Stock Tests Key SupportLast Point Resistance - newsline.com
Sight Sciences (SGHT) grants RSU award to board director - Stock Titan
Sight Sciences (SGHT) director awarded 28,261 RSUs worth about $130,000 - Stock Titan
Sight Sciences (SGHT) grants $130K in RSUs to board director - Stock Titan
Sight Sciences (SGHT) director Donald Zurbay awarded 28,261 RSUs valued at about $130,000 - Stock Titan
Sight Sciences (NASDAQ: SGHT) director receives 28,261 RSUs grant - Stock Titan
Sight Sciences (NASDAQ: SGHT) reports 2026 shareholder meeting voting results - Stock Titan
Sight Sciences (SGHT) Q1 earnings: How key metrics compare to Wall Street estimates - MSN
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates - Eastern Progress
Sight Sciences Inc. (SGHT) Nears Key Support After 3.95% DeclineTrading Ideas - The Legal Advocate
Sight Sciences Inc stock (US8177721062): Nasdaq-listed eye-care player sees muted trading ahead of Q - AD HOC NEWS
Sight Sciences Inc. (SGHT) Nears Support as Shares Edge LowerMoving Average Crossovers - newsline.com
SGHT Maintained by Citigroup -- Price Target Raised to $5.15 - GuruFocus
Sight Sciences Drops in Pre-Market Trade as Investors Watch SGHT Growth - Bez Kabli
Sight Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Bauerlein Alison - Moomoo
Sight Sciences wins $34M patent ruling against Alcon - MSN
Sight Sciences Inc. (SGHT) Q1 2026 Earnings: EPS Misses Estimates as Operating Losses WidenEarnings Growth Analysis - Newser
Sight Sciences Inc. (SGHT) Q1 2026 Earnings: Wider-Than-Expected Loss Drags Stock Down Over 2%Tax Rate Impact - Newser
Sight Sciences stock (US8177721062): eye-care specialist in focus after latest business update - AD HOC NEWS
Sight Sciences (SGHT) Q1 2026 Results Disappoint — Multiple Headwinds CitedSocial Buzz Stocks - Newser
Sight Sciences (SGHT) Fell -0.64% — Is a Recovery Ahead? 2026-05-20Sector Neutral Pair - Newser
Sight Sciences (SGHT) COO sells 12,728 shares to cover RSU tax obligations - Stock Titan
Sight Sciences stock (US8177721062): eye-care specialist in focus after recent earnings and FDA upda - AD HOC NEWS
Sight Sciences appoints Ali Bauerlein as COO and Jim Rodberg as CFO - MSN
Sight Sciences signals $83M-$89M 2026 revenue outlook while targeting $6M-$8M dry eye sales - MSN
sight sciences, inc. Earnings dates - RTTNews
Affiliate plans sale of 12,728 SGHT shares (NASDAQ: SGHT) via Fidelity - Stock Titan
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
TradingKey - TradingKey
Sight Sciences (SGHT) Climbs +2.86% — Resistance at $5.29 in Focus 2026-05-14Price Target - newsline.com
SGHT (Sight Sciences) posts wider-than-expected loss as earnings miss forecasts by 42%, shares dip.Wall Street Picks - Newser
Sight Sciences (SGHT) Q1 Loss Of US$0.24 EPS Tests Margin Improvement Narrative - Sahm
Sight Sciences Inc Stock (SGHT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):